# TOCILIZUMAB IN FIBROUS DYSPLASIA OF BONE

> **NCT01791842** · PHASE2 · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 19 (actual)

## Conditions studied

- Fibrous Dysplasia of Bone

## Interventions

- **DRUG:** Tocilizumab
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01791842
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05-05
- **Primary completion:** 2015-05
- **Final completion:** 2018-06-19
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2025-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01791842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01791842, "TOCILIZUMAB IN FIBROUS DYSPLASIA OF BONE". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01791842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*